A roadmap for management of chronic thromboembolic pulmonary hypertension. Issue 4 (24th October 2019)

• Record Type: Journal Article
• Authors: Jaïs, Xavier; Brenot, Philippe; Montani, David; Fadel, Elie; Humbert, Marc; Simonneau, Gérald
• Is Part Of: European respiratory journal. Volume 54:Issue 4(2019)
• Publication Date: 2019-10-24
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01295-2019
• Languages: English
• ISSNs: 0903-1936

Abstract

In a recent editorial published in the European Respiratory Journal, Lang and Matsubara [1] comment on the French experience of balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) in the context of international BPA experience [2]. The groundbreaking development of BPA techniques (initially developed in the USA by Feinstein et al. [3]) is widely recognised, and Matsubara and his Japanese colleagues should be congratulated for refining this treatment [4]. In the mid-2010s, BPA was implemented in high-volume expert centres in Europe, including France and Germany [2, 5]. Multicentre consortia should now produce stronger data both from randomised controlled trials and multicentre registries, in order to implement CTEPH guidelines http://bit.ly/2TWnaJ3